Outcomes of patients treated with activated protein C for severe sepsis

被引：0
|
作者：
McDonald, A. H. J. [1 ]
Swann, D. G. [1 ]
机构：
[1] Royal Infirm Edinburgh NHS Trust, Crit Care, Edinburgh EH16 4SA, Midlothian, Scotland
来源：
SCOTTISH MEDICAL JOURNAL | 2007年 / 52卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：51 / 52
页数：2
相关论文
共 50 条
  • [41] Recombinant human activated protein C for use in severe sepsis
    Bearden, DT
    Garvin, CG
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (09) : 1424 - 1429
  • [42] Recombinant human activated protein C for severe sepsis in neonates
    Kylat, Ranjit I.
    Ohlsson, Arne
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (04):
  • [43] Should we treat severe sepsis with activated protein C?
    Mackillop, A
    HOSPITAL MEDICINE, 2003, 64 (05): : 316 - 316
  • [44] Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated)
    Andrew F Shorr
    Jonathan M Janes
    Antonio Artigas
    Jyrki Tenhunen
    Duncan LA Wyncoll
    Emmanuelle Mercier
    Bruno Francois
    Jean-Louis Vincent
    Burkhard Vangerow
    Darell Heiselman
    Amy G Leishman
    Yajun E Zhu
    Konrad Reinhart
    Critical Care, 14
  • [45] Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated)
    Shorr, Andrew F.
    Janes, Jonathan M.
    Artigas, Antonio
    Tenhunen, Jyrki
    Wyncoll, Duncan L. A.
    Mercier, Emmanuelle
    Francois, Bruno
    Vincent, Jean-Louis
    Vangerow, Burkhard
    Heiselman, Darell
    Leishman, Amy G.
    Zhu, Yajun E.
    Reinhart, Konrad
    CRITICAL CARE, 2010, 14 (06):
  • [46] FUNCTIONAL PROTEIN C IN SEVERE SEPTIC PATIENTS TREATED WITH DROTRECORGINA ALFA ACTIVATED
    Lafuente, E.
    Pratima, I.
    Fernandes, M. J.
    da Silva, J. Gomes
    Moura, F.
    Santos, F.
    Lopes, R.
    Santos, P.
    INTENSIVE CARE MEDICINE, 2009, 35 : 240 - 240
  • [47] Functional protein C in severe septic patients treated with drotrecorgina alfa activated
    Lafuente, E.
    Pratima, I.
    Fernandes, M. J.
    Silva, J. G.
    Moura, F.
    Santos, F.
    Lopes, R.
    Santos, P.
    SHOCK, 2008, 29 : 111 - 112
  • [48] Patterns of survival in patients with severe sepsis treated with drotrecogin alfa (activated)
    Williams, MD
    Macias, W
    Nelson, D
    CHEST, 2004, 126 (04) : 723S - 723S
  • [49] Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated)
    Levi, Marcel
    Levy, Mitchell
    Williams, Mark D.
    Douglas, Ivor
    Artigas, Antonio
    Antonelli, Massimo
    Wyncoll, Duncan
    Janes, Jonathan
    Booth, Frank V.
    Wang, Dazhe
    Sundin, David P.
    Macias, William L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (05) : 483 - 490
  • [50] Drotrecogin alfa (activated) prevented and reversed Protein C deficiency in adult severe sepsis patients
    Macias, WL
    Levi, MM
    Nelson, DR
    Bernard, GR
    Dhainaut, JF
    CHEST, 2004, 126 (04) : 780S - 780S
12345